인트론바이오

048530KOSDAQView the 제약 sectorTheme Bio & healthcare

3,000KRWMarket close of 10/20 (Tue)

Up +6.76%+190KRWMarket close of 10/20 (Tue)

Preliminary value right after the close — replaced by official KRX data tomorrow morningClose of 10/21 (Wed)2,920KRWDown -2.67%

Preliminary · just after the close · replaced by official KRX data tomorrow morning

Open: 2,855
High: 3,500
Low: 2,825
Day range: Day range low 2,825 high 3,500, open 2,855, close 3,000, previous close 2,810
Volume: 581×10K shares
: 18.6B KRW 79.86× the 20-session average

Market close of 10/20 (Tue)

Where it sits in the 1-year range

16% of the way up from the lowest close in 1 year (252 sessions) · -54.9% from the high

Several things to check

3 to check: bigger daily move than usual · more trading value than usual · operating loss

Free · no sign-inSource from 2021-05-17

Points to check

Daily moveto check+6.76%+6.76%, 3.5× the usual (20-session average ±1.91%)
That day +6.76% · usual ±1.91% · large-move threshold ±3.8%
Trading valueto check79.9×18.6B KRW, 79.9× the 20-session average
79.86× the 20-session average · check threshold 3×
Earningsto check-7.9B KRWOperating income over the last four quarters -7.9B KRW (loss)Operating income, 8 quarters

The other 3

Recent filingsnot verified
Foreign & institutionalnot verified
Data date10/20 (Tue)Market close

See the full check report

Key figures

: 92.7B KRW
: Not computed — loss-making, or the four quarters are incomplete
: 1.33×
: 30,891,758 shares
Trading value ratio: 79.86× the 20-session average79.9×

52-week closing rangeNow 3,000

2,3306,650

Financials filed 2026-03-11 · KRX·DART

Several things to check

3 to check: bigger daily move than usual · more trading value than usual · operating loss

Daily moveto check+6.76% on the reference date, placed against the usual ±1.91% band3.5×
Trading valueto check79.86× the 20-session average79.9×
Earningsto checkQuarterly operating income bars (6); the four dark bars make up the sum-7.9B KRW
Recent filingsnot verifiedOutside filing data coverage, so not verified
Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified
Data dateusual rangeMarket close data of 2026-10-20

Quarterly results · Q4 2025

Source: DART financials (Q4 derived as annual − three quarters) · Amended filing reflected

Revenue1.7B KRWRevenue bars for the last 8 quarters; the dark bar is this quarter
vs. year ago
+12.0%
vs. prior quarter
+5.0%
Operating income-2.0B KRWOperating income bars for the last 8 quarters; the dark bar is this quarter
vs. year ago
Still a loss
vs. prior quarter
Still a loss
Operating margin-119.8%Operating margin bars for the last 8 quarters; the dark bar is this quarter
vs. year ago
-31.7 pp
vs. prior quarter
+7.5 pp

This quarter is derived: annual results minus Q1–Q3.

Quarterly operating income trend

As of the latest official close · 2026-10-20Valuation filing date · 2026-03-11

2021Q1 1.5B KRW2025Q4 -2.0B KRWQ4 values are derived as the annual figure minus Q1–Q3. The value table marks them in the Type column.

Same sector · 제약

· 29 of 168 stocks up, preferred shares excluded · trading value 827.8B KRW

Same sector · top by trading value
Stock	20D	Change	Trading value
셀트리온	Close over the last 20 sessions +11.4%	Down -0.40%	139.2B KRW
삼성바이오로직스	Close over the last 20 sessions -1.3%	Down -2.52%	129.9B KRW
삼익제약	Close over the last 20 sessions -20.4%	Up +2.77%	76.0B KRW
녹십자엠에스	Close over the last 20 sessions +30.5%	Up +6.67%	55.6B KRW
유한양행	Close over the last 20 sessions +11.5%	Down -1.37%	41.6B KRW

Schedule

Next data 10/22 (Thu) after 08:50

Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 81% of trading value, about 92% of market capitalisation. Coverage status →

For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.